Preservation of insulin C-peptide in pregnant women with type 1 diabetes mellitus

Not Applicable

Completed

• Conditions: Type 1 diabetes mellitus in pregnant women; Nutritional, Metabolic, Endocrine; Type 1 diabetes mellitus

• Registration Number: ISRCTN15203878
• Lead Sponsor: niversity of Zagreb, School of Medicine

Brief Summary

2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28378851 results 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34210228/ (added 10/10/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-09-15
• Study Completion: 2021-12-31
• Last Update Posted: 23 October 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 111

Inclusion Criteria

1. Pregnant women
2. Diagnosis of type 1 diabetes
3. Provision of informed consent
4. Aged between 18-40 years

Exclusion Criteria

Type 1 diabetic patients whose pregnancy terminated as preterm delivery

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
FC-peptide concentration is measured by the electrochemiluminescence immunoassay ECLIA” at baseline, 20 weeks gestation, 30 weeks gestation and at delivery.